 |
NetWellness provides the highest quality health information and education services created and evaluated by faculty of our partner universities.
Friday, March 19, 2010
|
|
|
NetWellness provides the highest quality health information and education services created and evaluated by faculty of our partner universities.
Friday, March 19, 2010
|
Cancer |
Liver Cancer Operation07/23/2009 |
Is there anyone that will still operate on a HCC liver with 12.4 Bilirubin and portal vain obstruction? Or give any other treatment at that (theraspheres, tace, avastin etc.?)
The answer to your question, sadly, is no. Anyone with a bilirubin as high as yours is at significant risk for liver failure and death if one proceeds with surgery. I do not know how much of your liver needs to be removed, however. In addition, portal vein thrombosis is another very serious risk for poor outcomes following liver surgery.
Unfortunately, with a Bilirubin that high, just about anything we can do to your liver may very seriously affect its function and hence your survival. No one I know of would perform theraspheres or tace. There is little role or avastin in HCC. Depending upon how large your tumor is, and where it is located, someone may be aggressive enough to ablate the tumor. This would still be risky, but much less so than doing a resection (removing a piece of the liver). I hope this helps and best wishes.
|
Steve Rudich, MD, PhD, FACS Associate Professor of Surgery Director, Liver Transplant Services Department of Surgery College of Medicine University of Cincinnati |
|
|
|
Please note: only your personal physician or other health professional you consult can best advise you on matters of your health based on your medical history, your family medical history, your medication history, and how information from any of these databases may apply to you. Neither University of Cincinnati (NetWellness) nor any party involved in creating, producing or delivering this web site shall be liable for any damages arising out of access to or use of this web site, or any errors or omissions in the content thereof. (More) 
|